Your First Month on Mounjaro: What Actually Happens

Week one: you've taken the first injection, now what?

You've found the right injection site, rotated as the leaflet says, and put the pen back in the fridge. For most people, the first week feels unremarkable. The 2.5 mg dose is calibrated to let your digestive system adapt; it is not the dose that drives significant weight loss. That purpose comes later.

Some people notice a faint reduction in appetite by day four or five. Others feel nothing different at all. Both experiences are normal. Nausea, if it arrives, tends to show up in the first few days after each injection and then soften. Keeping meals small and plain during this window helps more than you might expect.

A practical habit worth building in week one: weigh yourself on the same morning, at the same time, in the same clothing (or none), and note it. One data point means nothing; a consistent baseline means you have something honest to compare later. That single minute each week becomes one of the most useful things you do.

The full clinical profile of tirzepatide explains the dual GIP and GLP-1 mechanism driving these appetite changes, if you want the detail behind what you're experiencing.

Weeks two and three: appetite starts to shift more clearly

This is often when people notice they're leaving food on the plate without trying. Portion sizes shrink naturally. The urge to snack between meals fades. These are not willpower wins, they reflect how tirzepatide works on the hormones that signal fullness and regulate how quickly food leaves the stomach.

Side effects are still most likely here, particularly after the second injection. Nausea is the most commonly reported. Loose stools, constipation, indigestion, and a vague fatigue are also possible. For most people these are mild and manageable. If vomiting or diarrhoea is severe enough to make staying hydrated difficult, that warrants a call to your prescriber, not because it signals something dangerous in itself, but because dehydration on top of reduced eating can become a problem quickly.

Weight change in weeks two and three varies considerably between people. Some see a noticeable drop; others see very little yet. Early movement often reflects fluid shifts as much as fat loss. The average weight loss figures at one month give useful context, but averages cover a wide spread of individual results.

Week four: completing the first pen and looking ahead

By week four you've used all four doses in the pen. Your prescriber will want to know how you've tolerated the 2.5 mg dose before deciding whether to move to 5 mg or stay for another month. This review is genuinely clinical, it considers side effect severity, how your appetite has responded, and your overall health picture, not just a number on the scales.

At this point, some people ask whether they can do Mounjaro for one month only. It's a fair question. One month on Mounjaro gives you a reasonable read on tolerability, but it is not long enough to assess whether the medicine is working as a weight-management treatment. The SURMOUNT-1 trial (the largest tirzepatide weight-loss study, which enrolled over 2,500 adults) ran for 72 weeks, and the most meaningful weight reductions accumulated over months, not weeks. The NHS tirzepatide guidance reflects that sustained treatment is where the clinical benefit lies.

That said, the decision to continue is always yours in collaboration with your prescriber. If you're weighing up the longer-term commitment, the cost picture for Mounjaro over time is worth reading, and what month two typically looks like gives a clearer sense of where most people see more noticeable progress.

At nume, your prescription is reviewed again before every repeat order, a real prescriber reads your update, not an automated system. If you have questions between injections, our aftercare team is available seven days a week. For a broader look at what treatment with us involves, our clinical approach sets out how we work. If you're still weighing whether Mounjaro is right for your situation, changes to body composition can affect different areas in ways people don't always anticipate, and reading about how Mounjaro can affect the fanny area is one of the topics our patients find worth exploring before committing. The free consultation is the right starting point, no obligation, reviewed the same day by a GPhC-registered Independent Prescriber.